Double Medical Technology, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000032W7
CNY
41.90
-1.27 (-2.94%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
641.50
724.60
665.82
660.10
550.34
606.30
565.13
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
641.50
724.60
665.82
660.10
550.34
606.30
565.13
Raw Material Cost
165.75
235.61
197.09
192.97
176.23
195.38
172.75
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.31
1.27
0.99
1.79
2.12
0.97
0.99
Selling and Distribution Expenses
203.76
227.15
210.69
204.42
182.54
214.21
191.77
Other Expenses
7.76
7.70
8.68
7.80
7.07
8.80
7.46
Total Expenditure (Excl Depreciation)
448.39
540.99
495.52
477.19
431.59
498.56
440.10
Operating Profit (PBDIT) excl Other Income
193.1
183.6
170.3
182.89999999999998
118.69999999999999
107.69999999999999
125
Other Income
7.13
50.47
36.98
18.80
26.32
54.68
11.77
Operating Profit (PBDIT)
175.05
270.90
246.73
227.44
188.83
196.67
176.55
Interest
1.31
1.27
0.99
1.79
2.12
0.97
0.99
Exceptional Items
10.59
5.79
29.59
5.82
2.30
2.07
6.08
Gross Profit (PBDT)
475.75
489.00
468.73
467.13
374.11
410.92
392.38
Depreciation
0.00
59.72
59.72
60.87
60.87
57.02
57.02
Profit Before Tax
184.33
215.70
215.61
170.61
128.13
140.75
124.61
Tax
22.44
27.64
26.02
23.91
15.59
18.61
12.27
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
146.57
174.99
180.39
141.16
103.10
116.93
101.63
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
146.57
174.99
180.39
141.16
103.10
116.93
101.63
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
15.32
13.07
9.20
5.54
9.44
5.22
10.71
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
161.89
188.06
189.58
146.70
112.54
122.14
112.34
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,724.41
3,570.00
3,336.57
3,143.12
3,193.86
3,078.99
3,163.19
Earnings per share (EPS)
0.36
0.42
0.44
0.35
0.25
0.28
0.25
Diluted Earnings per share
0.36
0.42
0.44
0.35
0.25
0.28
0.25
Operating Profit Margin (Excl OI)
26.18%
22.18%
22.53%
22.39%
18.47%
14.01%
19.07%
Gross Profit Margin
28.74%
38.01%
41.35%
35.07%
34.34%
32.62%
32.14%
PAT Margin
22.85%
24.15%
27.09%
21.38%
18.73%
19.29%
17.98%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -11.47% vs 8.83% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -13.93% vs -0.79% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -23.82% vs 5.10% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 30.00% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Double Medical Technology, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
641.50
0
641.50
Other Operating Income
0.00
0.00
0.00
Total Operating income
641.50
0
641.50
Raw Material Cost
165.75
0
165.75
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.31
0
1.31
Selling and Distribution Expenses
203.76
0
203.76
Other Expenses
7.76
0.00
7.76
Total Expenditure (Excl Depreciation)
448.39
0
448.39
Operating Profit (PBDIT) excl Other Income
193.10
0.00
193.10
Other Income
7.13
0
7.13
Operating Profit (PBDIT)
175.05
0
175.05
Interest
1.31
0
1.31
Exceptional Items
10.59
0
10.59
Gross Profit (PBDT)
475.75
0
475.75
Depreciation
0.00
0
0.00
Profit Before Tax
184.33
0
184.33
Tax
22.44
0
22.44
Provisions and contingencies
0
0
0.00
Profit After Tax
146.57
0
146.57
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
146.57
0
146.57
Share in Profit of Associates
0
0
0.00
Minority Interest
15.32
0
15.32
Other related items
0.00
0.00
0.00
Consolidated Net Profit
161.89
0
161.89
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,724.41
0
3,724.41
Earnings per share (EPS)
0.36
0
0.36
Diluted Earnings per share
0.36
0
0.36
Operating Profit Margin (Excl OI)
26.18%
0%
0.00
26.18%
Gross Profit Margin
28.74%
0%
0.00
28.74%
PAT Margin
22.85%
0%
0.00
22.85%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 64.15 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -11.47% vs 8.83% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 16.57% vs 28.79% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 16.19 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -13.93% vs -0.79% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 43.91% vs 67.41% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.79 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -23.82% vs 5.10% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 3.32% vs 47.73% in Mar 2025

Quarterly - Interest
Interest 0.13 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 30.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -38.10% vs -22.22% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.18%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025